【IAS】Guest Lecture “Regenerative Medicine for Sale: The Governance of Private DTC RM Therapies” by Prof. Yann Joly (16 June 2025, 3-4:30 pm)

【高研院】嘉賓講座：”Regenerative Medicine for Sale: The Governance of Private DTC RM Therapies“ - Yann Joly教授（2025年6月16日；下午3時-4時半）

 2025-06-10     IAS     Conference/Symposium / 會議/研討會 
The IAS promotional video has been launched! We cordially invite you to watch and help spread the word! 

English

 

中文
On the occasion of the fifth anniversary of the Institute for Advanced Studies in Humanities and Social Sciences at the University of Macau, we would like to express our gratitude for your unwavering support to us. Your involvement and support have helped build a strong foundation for our interdisciplinary research platform and inspired us to keep moving forward. The IAS is excited to carry on our mission, rooted in Macau, by organizing high-quality academic activities that showcase the diversity of academic collaboration.

 

Dear Colleagues and Students,

The Institute of Advanced Studies in Humanities and Social Sciences (IAS) warmly invites you to attend the upcoming IAS Guest Lecture, titled “Regenerative Medicine for Sale: The Governance of Private DTC RM Therapies.” Please find the details below:

Details

  • Speaker: Prof. Yann Joly (Professor, Faculty of Medicine and Health Sciences, Department of Human Genetics, McGill University)
  • Moderator: Prof. Li Du (Associate Professor, Faculty of Law, University of Macau)
  • Discussant: Prof. Yuanjia Hu (Professor, Institute of Chinese Medical Sciences; Director, Centre for Pharmaceutical Regulatory Sciences, University of Macau)
  • Date: 16 June 2025 (Monday)
  • Time: 3:00 – 4:30 PM
  • Language: English
  • Venue: Lecture Hall, Cultural Building (E34-G011)
  • Registration: https://go.um.edu.mo/uw86xnr6

Abstract

This presentation explores the evolving landscape of direct-to-consumer (DTC) sales in regenerative medicine (RM), tracing its development across three distinct waves. The first wave, often described as stem cell tourism, involved patients traveling abroad to access unproven and loosely regulated stem cell interventions. This presentation will introduce a third wave, examine the socio-technical and commercial drivers behind its growth, and critically analyze the legal and ethical challenges it raises, including concerns around safety, efficacy, informed consent, consumer protection, and regulatory gaps.

 

All information will be simultaneously released on IAS social media platforms.

Facebook Instagram Xiaohongshu  WeChat
Click here Click here Click here

 

We look forward to seeing you at this event! For more information about IAS, please visit the website at https://ias.um.edu.mo/. Should you have any questions, please do not hesitate to contact us at ias.programme@um.edu.mo.

 

Best regards,
The Institute of Advanced Studies in Humanities and Social Sciences